Development and validation of a rapid HPLC assay for the simultaneous determination of three psychoanaleptic drugs in pharmaceutical formulations

Journal of Liquid Chromatography and Related Technologies

Volumn 31, Issue 5, 2008, Pages 722-732

  Nagaraju, V ^a   Crouch, A M ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Atomoxetine; Fluoxetine; Pharmaceutical formulations; Reversed phase HPLC; Venlafaxine

Indexed keywords

ACETONITRILE; DRUG THERAPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHOSPHORIC ACID;

LIMIT OF QUANTITATION (LOQ); ROOM TEMPERATURE; VENLAFAXINE;

DRUG PRODUCTS;

ACETONITRILE; ATOMOXETINE; CENTRAL STIMULANT AGENT; EXCIPIENT; FLUOXETINE; PHOSPHORIC ACID; POTASSIUM DIHYDROGEN PHOSPHATE; VENLAFAXINE;

ACCURACY; ARTICLE; DRUG DETERMINATION; DRUG FORMULATION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; QUANTITATIVE ANALYSIS; ROOM TEMPERATURE; SENSITIVITY AND SPECIFICITY; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

EID: 38649084400     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070701854378     Document Type: Article

References (22)

1. Gehlert, D.R.; Gackenheimer, S.L.; Roberson, D.W. Localization of rat brain binding sites for [3H] tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sites. Neurosci. Lett. 1993, 157, 203-206.
2. Lynch, T. Atomoxetine for ADHD. Am. Fam. Physican 2003, 68, 1827-1828.
3. Safer, D.J. Atomoxetine: a viewpoint. Pediatr. Drugs 2003, 5, 416.
4. Montgomery, S.A. Rapid onset of action of venlafaxine. Int. Clin. Psychopharmacol. 1995, 10, suppl 2, 21-27.
5. http://psyweb.com/Drughtm/jsp/venlaf.jsp.
6. Cornelius, J.R.; Salloum, I.M.; Cornelius, M.D.; Perel, J.M.; Thase, M.E.; Ehler, J.G.; Mann, J.J. Fluoxetine trial in suicidal depressed alcoholics. Psychopharmacol. Bull. 1993, 29, 195-199.
7. Dunner, D.L. Treatment of dysthymic disorder. Depression & Anxiety 1998, 8 (1), 54-58.
8. Mukhija, S.N.; Vavia, P.R. Stability indicating LC method for the estimation of venlafaxine in pharmaceutical formulations. J. Pharm. Biomed. Anal. 2002, 28, 1055-1059.
9. Gowri Shankar, D.; Vamsi Krishna, M.; Latha, P.V.M. ICH guidance in practice: stability indicating HPLC assay method of venlafaxine in bulk form solid dosage forms. Oriental J. Chem. 2005, 21, 591-596.
10. do Prado, J.N.; Pissatto, S.; de Morais, E.C.; Foppa, T.; Murakami, F.S.; Silva, M.A.S. Validation of a high performance liquid chromatographic method for the analysis of fluoxetine capsules. Acta Farmaceutica Bonaerense 2006, 25, 436-440.
11. Raggi, M.A.; Bugamelli, F.; Casamenti, G.; Mandrioli, R.; De Ronchi, D.; Volterra, V. Analytical methods for the quality control of Prozac capsules. J. Pharma. Biomed. Anal. 1998, 18, 699-706.
12. Zhu-fen, L.; Qing-Chun, X.; Seng, L. HPLC method for the determination of fluoxetine capsules. Guangdong Yaoxue 2005, 15, 13-15.
13. Berzas, J.J.; Guiberteau, C.; Contento, A.M.; Rodriguez, V. Sensitive and rapid high-performance liquid chromatographic method for simultaneous determination of antidepressants in pharmaceutical formulations. Chromatographia 2002, 56, 545-551.
14. Yilmaz, N.; Ozkan, Y.; Ozkan, S.A.; Biryol, I.; Aboul-Enein, H.Y. High performance liquid chromatographic assay and drug dissolution studies of fluoxetine hydrochloride in capsule formulations. J. Liq. Chromatogr. & Rel. Technol. 2000, 23, 1699-1710.
15. Berzas, J.J.; Guiberteau, C.; Villasenor, M.J.; Rodriguez, V. Development of a capillary gas chromatographci procedure. Anal. Chim. Acta 2004, 519, 219-230.
16. Berzas, J.J.; Villasenor Llerena, M.J.; Contento Salcedo, A.M.; Aguas Nuevo, E. Assay validation for three antidepressants in pharmaceutical formulations: practical approach using capillary gas chromatography. J. Pharm. Biomed. Anal. 2005, 38, 52-59.
17. Buzinkaiova, T.; Polonsky, J. Determination of four selective serotonin reuptake inhibitors by capillary isotachophoresis. Electrophoresis 2000, 21, 2839-2841.
18. Berzas, J.J.; Contento Salcedo, A.M.; Villasenor Llerena, M.J.; Aguas Nuevo, E. Method development validation for the simultaneous determination of fluoxetine and fluvoxamine in pharmaceutical preparations by capillary electrophoresis. Anal. Chim. Acta 2000, 417, 169-176.
19. Patel, C.; Patel, M.; Rani, S.; Nivasarkar, M.; Padh, H. A new high performance liquid chromatographic method for quantification of atomoxetine in human plasma and its application for pharmacokinetic study. J. Chromatogr. B 2007, 850, 356-360.
20. Zhu, H.-J.; Wang, J.-S.; Donovan, J.L.; De Vane, C.L.; Gibson, B.B.; Markowitz, J.S. Sensitive quantification of atomoxetine in human plasma by HPLC with fluorescence detection using 4-(4,5-diphenyl-1H-imidazole-2-yl) benzoyl chloride derivatization. J. Chromatogr. B 2006, 846, 351-354.
21. Gavin, P.F.; Olsen, B.A.; Wirth, D.D.; Lorenz, K.T. A quality evaluation strategy for multi-sourced active pharmaceutical ingredient (API) starting materials. J. Pharm. Biomed. Anal. 2006, 41, 1251-1259.
22. Sellers, J.A.; Olsen, B.A.; Owens, P.K.; Gavin, P.F. Determination of the enantiomer and positional isomer impurities in atomoxetine hydrochloride with liquid chromatography using polysaccharide chiral stationary phases. J. Pharm. Biomed. Anal. 2006, 41, 1088-1094.